approval
savePRALUENT (ALIROCUMAB) — FDA approval
community read0 votes
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalPRALUENT (ALIROCUMAB) — FDA approvalOct 9, 2025 · 407d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 8, 2024 · 987d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2059d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2059d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 10, 2020 · 2446d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2765d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2765d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalAug 22, 2018 · 3012d ago
comments(0)
5-min edit window · permanent after that